Abstract:Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. The high mortality is directly associated with metastatic disease, which is thought to be initiated by colon cancer stem cells, according to the cancer stem cell (CSC) model. Consequently, early identification of those patients who are at high risk for metastasis is crucial for improved treatment and patient outcomes. Metastasis-associated in colon cancer 1 (MACC1) is a novel prognostic biomarker for tumor progression and metastasis formation independent of tumor stage. We previously showed an involvement of MACC1 in cancer stemness in the mouse intestine of our MACC1 transgenic mouse models. However, the expression of MACC1 in human CSCs and possible implications remain elusive. Here, we explored the molecular mechanisms by which MACC1 regulates stemness and the CSC-associated invasive phenotype based on patient-derived tumor organoids (PDOs), patient-derived xenografts (PDXs) and human CRC cell lines. We showed that CD44-enriched CSCs from PDO models express significantly higher levels of MACC1 and LGR5 and display higher tumorigenicity in immunocompromised mice. Similarly, RNA sequencing performed on PDO and PDX models demonstrated significantly increased MACC1 expression in ALDH1(+) CSCs, highlighting its involvement in cancer stemness. We further showed the correlation of MACC1 with the CSC markers CD44, NANOG and LGR5 in PDO models as well as established cell lines. Additionally, MACC1 increased stem cell gene expression, clonogenicity and sphere formation. Strikingly, we showed that MACC1 binds as a transcription factor to the LGR5 gene promoter, uncovering the long-known CSC marker LGR5 as a novel essential signaling mediator employed by MACC1 to induce CSC-like properties in human CRC patients. Our in vitro findings were further substantiated by a significant positive correlation of MACC1 with LGR5 in CRC cell lines as well as CRC patient tumors. Taken together, this study indicates that the metastasis inducer MACC1 acts as a cancer stem cell-associated marker. Interventional approaches targeting MACC1 would potentially improve further targeted therapies for colorectal cancer patients to eradicate CSCs and prevent cancer recurrence and distant metastasis formation.

MACC1 promotes carcinogenesis of colorectal cancer via β-catenin signaling pathway.

MACC1 promotes carcinogenesis of colorectal cancer via beta-catenin signaling pathway

Silence of MACC1 Decreases Cell Migration and Invasion in Human Malignant Melanoma Through Inhibiting the EMT.

Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) overexpression in colorectal cancer: a meta-analysis.

MACC1 induces autophagy to regulate proliferation, apoptosis, migration and invasion of squamous cell carcinoma

Macc1 Down-Regulation Inhibits Proliferation And Tumourigenicity Of Nasopharyngeal Carcinoma Cells Through Akt/Beta-Catenin Signaling Pathway

MACC1 Promotes the Progression and Is a Novel Biomarker for Predicting Immunotherapy Response in Colorectal Cancer

MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer

Metastasis Associated in Colon Cancer 1 (MACC1) Promotes Growth and Metastasis Processes of Colon Cancer Cells.

MACC1 Regulates LGR5 to Promote Cancer Stem Cell Properties in Colorectal Cancer

MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer

Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9

MACC1 Overexpression in Carcinoma‑associated Fibroblasts Induces the Invasion of Lung Adenocarcinoma Cells Via Paracrine Signaling.

MACC1-AS1 Promotes Hepatocellular Carcinoma Cell Invasion and Proliferation by Regulating PAX8

MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway.

MACC1 Contributes to the Development of Osteosarcoma Through Regulation of the HGF/c-Met Pathway and Microtubule Stability

Macc1: A Potential Molecule Associated With Pancreatic Cancer Metastasis And Chemoresistance

Metastasis-associated in Colon Cancer-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma, Partly by Promoting Proliferation Through Enhanced Glucose Metabolism.

FOXM1 promotes the growth and metastasis of colorectal cancer via activation of β-catenin signaling pathway

MACC1 - more than metastasis? Facts and predictions about a novel gene

MACC1 supports human gastric cancer growth under metabolic stress by enhancing the Warburg effect